Blood pressure monitor maker Omron Healthcare has gotten approval for a new home monitor that can detect atrial fibrillation.
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
This dedication to good health makes Jolina the ideal brand ambassador for OMRON Healthcare business in the Philippines, the country’s leading provider of health monitoring and management solutions.
OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
Founded by Kazuma Tateishi, OMRON’s mission has always been about empowering people to take charge of their health. The company has spent over 50 years developing innovative solutions for ...
"Omron's resilience through the pandemic was thanks to our mission of empowering health and reducing risk for Filipinos. Our ...
This dedication to good health makes Jolina the ideal brand ambassador for OMRON Healthcare business in the Philippines, the country’s leading provider of health monitoring and management solutions.